Expanding the phenotypic spectrum of TRAF7 -related CAFDADD: report of eleven new cases and literature review.

Carmen Palma-Milla,Aina Prat-Planas,Emma Soengas-Gonda,Mónica Centeno-Pla,Jaime Sánchez-Pozo,Irene Lazaro-Rodriguez,Juan F. Quesada-Espinosa,Ana Arteche-Lopez,Jonathan Olival,Marta Pacio-Miguez,María Palomares-Bralo,Fernando Santos-Simarro,Ramón Cancho-Candela,María Vázquez-López,Veronica Seidel,Antonio F. Martinez-Monseny,Didac Casas-Alba,Daniel Grinberg,Susanna Balcells,Mercedes Serrano,Raquel Rabionet,Miguel A. Martin,Roser Urreizti
DOI: https://doi.org/10.1016/j.pediatrneurol.2024.03.008
IF: 4.21
2024-03-16
Pediatric Neurology
Abstract:TRAF7 -related CAFDADD, a multisystemic neurodevelopmental disorder caused by germline missense variants in the TRAF7 gene, exhibits heterogeneous clinical presentations. We present a detailed description of eleven new TRAF7 -related CAFDADD cases, featuring eight distinct variants, including a novel one. Phenotypic analysis and a comprehensive review of the 58 previously reported cases outline consistent clinical presentations, emphasizing dysmorphic features, developmental delay, endocrine manifestations, and cardiac defects. In this enlarged collection, novelties include a wider range of cognitive dysfunction, with some individuals exhibiting normal development despite early psychomotor delay. Communication challenges, particularly in expressive language, are prevalent, necessitating alternative communication methods. Autistic traits, notably rigidity, are observed in the cohort. Also, worth highlighting are hearing loss, sleep disturbances, and endocrine anomalies, including growth deficiency. Cardiac defects, frequently severe, pose early-life complications. Facial features, including arched eyebrows, contribute to the distinct gestalt. A novel missense variant, p.(Arg653Leu), further underscores the complex relationship between germline TRAF7 variants and somatic changes linked to meningiomas. Our comprehensive analysis expands the phenotypic spectrum, emphasizing the need for oncological evaluations and proposing an evidence-based schedule for clinical management. This study contributes to a better understanding of TRAF7 -related CAFDADD, offering insights for improved diagnosis, intervention, and patient care.
pediatrics,clinical neurology
What problem does this paper attempt to address?